Checkpoint Trends
99.26
+1.94(+1.99%)
Market Cap₹49.16 Cr
PE Ratio33.15
IndustryHealthcare
Company Performance:
1D+1.99%
1M+54.35%
6M+384.43%
1Y+547.07%
5Y+2,002.97%
View Company Insightsright
More news about Checkpoint Trends
19Sept 25
Checkpoint Trends Limited to Reassess Fund-Raising Plans in Upcoming Board Meeting
Checkpoint Trends Limited (BSE: 531099) has scheduled a board meeting for September 24, 2025, to reassess fund-raising decisions made on September 10, 2025. The board will evaluate revised proposals for capital raising through preferential allotment, convertible warrants, Qualified Institutional Placement (QIP), and other permissible instruments. The company will also reconsider the date for its Extra-ordinary General Meeting, initially set for October 13, 2025. This development has been communicated to BSE Limited in compliance with SEBI regulations.
16Sept 25
Checkpoint Trends Limited Announces CFO Transition: Abha Kapoor Resigns, Shubham Chaudhary Takes the Helm
Checkpoint Trends has announced changes in its top finance leadership. Ms. Abha Rajesh Kapoor has resigned as Whole-Time Director and Chief Financial Officer, effective September 16, 2025, citing personal reasons. Mr. Shubham Chaudhary, currently a Whole-Time Director, will take over as the new Chief Financial Officer effective September 17, 2025. Mr. Chaudhary brings over eight years of experience in marketing, sales strategies, and team leadership.
18Aug 25
Checkpoint Trends Limited Plans Fourfold Increase in Authorized Share Capital, Diversifies into Tobacco and Edible Oils
Checkpoint Trends Limited (BSE: 531099) has announced significant changes to its corporate structure and business focus. The company plans to increase its authorized share capital from Rs. 75.00 crores to Rs. 300.00 crores, expanding equity shares from 7.50 crore to 30.00 crore. The company also aims to diversify into tobacco-related trading and the edible oils business. These changes are subject to shareholder approval through a postal ballot process with e-voting scheduled from August 21 to September 20, 2025. The company views these moves as strategic steps to optimize resources, enhance efficiency, and create sustainable value for stakeholders.
Checkpoint Trends
99.26
+1.94
(+1.99%)
1 Year Returns:+547.07%
Industry Peers
Sun Pharmaceutical
1,831.60
(+1.18%)
Divis Laboratories
6,477.00
(-0.21%)
Torrent Pharmaceuticals
3,720.60
(-0.26%)
Cipla
1,531.30
(+0.40%)
Dr Reddys Laboratories
1,258.80
(+0.76%)
Lupin
2,082.20
(+0.52%)
Zydus Life Science
942.50
(+0.56%)
Mankind Pharma
2,251.00
(+0.08%)
Aurobindo Pharma
1,226.70
(-0.74%)
Alkem Laboratories
5,685.00
(-0.03%)